ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Tennessee » Psychiatry

Top Psychiatry Prescribers in Tennessee

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENNY TERRY MD

Psychiatry

15,281

$2.12M

1403
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

15%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $117

CHARLES RODWELL MD

Psychiatry

15,210

$1.96M

771
108 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $117

ADRIAN BUCKNER MD

Psychiatry

11,459

$2.17M

907
150 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$189
Average prescription price

Avg: $117

JIM PANG M.D.

Psychiatry

10,973

$1.64M

653
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 24%

$150
Average prescription price

Avg: $117

PADMAVATHI GEDDAM MD

Psychiatry

9,727

$1.21M

598
98 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$125
Average prescription price

Avg: $117

TEJINDER SAINI M.D.

Psychiatry

9,607

$899K

784
120 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 24%

$94
Average prescription price

Avg: $117

NIANSEN LIU M.D.

Psychiatry

8,946

$924K

499
83 are 65+

3%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $117

KENNETH GREENWOOD MD

Psychiatry

8,836

$1.12M

423
46 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $117

ERIC MOFFET MD

Psychiatry

8,773

$834K

534
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 24%

$95
Average prescription price

Avg: $117

VISWA DURVASULA M.D.

Psychiatry

8,423

$867K

558
211 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $117

JAMES GRAVES M.D.

Psychiatry

7,858

$794K

426
61 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $117

BABULAL DUDANI MD

Psychiatry

7,793

$684K

467
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $117

JORGE LEAL MD

Psychiatry

7,544

$1.12M

522
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $117

ROBERT BALDWIN M.D.

Psychiatry

7,544

$1M

808
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

23%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $117

ESIRI ESIN M.D.

Psychiatry

7,523

$786K

781
120 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

2%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

21%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $117

JOSEPH WILLIAMS M.D.

Psychiatry

7,353

$806K

449
81 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$110
Average prescription price

Avg: $117

KEVIN FERGUSON M.D.

Psychiatry

7,319

$829K

475
106 are 65+

21%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 24%

$113
Average prescription price

Avg: $117

SABITHA HUDEK MD

Psychiatry

7,129

$957K

272
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $117

FERDINAND ARMAS M.D.

Psychiatry

7,042

$810K

453
55 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $117

RODNEY HOUGHTON MD

Psychiatry

6,954

$856K

490
348 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 24%

$123
Average prescription price

Avg: $117

RAVI SINGH MD, MPH

Psychiatry

6,579

$643K

404
272 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 24%

$98
Average prescription price

Avg: $117

SHABEER ABUBUCKER MD

Psychiatry

6,460

$946K

347
48 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$146
Average prescription price

Avg: $117

SHIRLEY TRENTHAM MD

Psychiatry

6,460

$736K

505
84 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $117

MERCY ISANG M.D.

Psychiatry

6,266

$819K

356
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 24%

$131
Average prescription price

Avg: $117

WILLIAM PETRIE MD

Psychiatry

6,166

$514K

455
358 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

3%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $117

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank